Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP84217.RApYMQWSKhermkWE7HYVPBNp4f_hQRqXDi0VCI_Sl22_8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP84217.RApYMQWSKhermkWE7HYVPBNp4f_hQRqXDi0VCI_Sl22_8130_assertion type Assertion NP84217.RApYMQWSKhermkWE7HYVPBNp4f_hQRqXDi0VCI_Sl22_8130_head.
- NP84217.RApYMQWSKhermkWE7HYVPBNp4f_hQRqXDi0VCI_Sl22_8130_assertion wasGeneratedBy ECO_0000203 NP84217.RApYMQWSKhermkWE7HYVPBNp4f_hQRqXDi0VCI_Sl22_8130_provenance.
- NP84217.RApYMQWSKhermkWE7HYVPBNp4f_hQRqXDi0VCI_Sl22_8130_assertion wasDerivedFrom gad-20130706 NP84217.RApYMQWSKhermkWE7HYVPBNp4f_hQRqXDi0VCI_Sl22_8130_provenance.
- NP84217.RApYMQWSKhermkWE7HYVPBNp4f_hQRqXDi0VCI_Sl22_8130_assertion SIO_000772 16397907 NP84217.RApYMQWSKhermkWE7HYVPBNp4f_hQRqXDi0VCI_Sl22_8130_provenance.
- NP84217.RApYMQWSKhermkWE7HYVPBNp4f_hQRqXDi0VCI_Sl22_8130_assertion evidence source_evidence_literature NP84217.RApYMQWSKhermkWE7HYVPBNp4f_hQRqXDi0VCI_Sl22_8130_provenance.
- NP84217.RApYMQWSKhermkWE7HYVPBNp4f_hQRqXDi0VCI_Sl22_8130_assertion description "[According to our data, the NAT2*5A and NAT2*6A mutant genotypes and NAT2*14A heterozygous genotype were associated with an increased risk of development of DM (OR = 47.06; 95%CI: 10.55-209.77 for NAT 2*5A, OR = 18.48; 95%CI: 3.83-89.11 for NAT2*6A and OR = 18.22; 95%CI: 6.29-52.76 for NAT2*14A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84217.RApYMQWSKhermkWE7HYVPBNp4f_hQRqXDi0VCI_Sl22_8130_provenance.